Advanced search
Publication Cover
Current Medical Research and Opinion Volume 21, 2005 - Issue 2
Submit an article Journal homepage
43
Views
20
CrossRef citations to date
0
Altmetric
Review

Have we forgotten the pivotal role of high-density lipoprotein cholesterol in atherosclerosis prevention?

Anthony S. Wierzbicki Department of Chemical Pathology, St. Thomas’ Hospital, London, UKCorrespondence[email protected]
Pages 299-305 | Accepted 10 Jan 2006, Published online: 14 Feb 2006

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Anthony S. Wierzbicki, Emmanuel S. Ganotakis & Dimitri P. Mikhailidis. (2007) Shape of the Nations survey and attitudes to cardiometabolic risk. Current Medical Research and Opinion 23:1, pages 25-28.
Read now
Hiroshi Mabuchi & Akihiro Inazu. (2006) Cholesteryl ester transfer protein inhibitors: new strategies for raising high-density lipoprotein cholesterol. Future Lipidology 1:4, pages 487-500.
Read now
Anthony Wierzbicki. (2006) Future approaches to reducing low-density lipoprotein cholesterol. Future Lipidology 1:4, pages 463-476.
Read now

Articles from other publishers (17)

Venugopalan Rajesh, Perumal Perumal & Ponnala Aruna. (2012) Hypolipidemic and antioxidant activity of grape skin extract and resveratrol on rats fed with high-fat diet. Oriental Pharmacy and Experimental Medicine 13:1, pages 11-20.
Crossref
Dina M. Schreinemachers. (2011) Association between Perchlorate and Indirect Indicators of Thyroid Dysfunction in NHANES 2001–2002, a Cross-Sectional, Hypothesis-Generating Study. Biomarker Insights 6, pages BMI.S7985.
Crossref
Dina M Schreinemachers. (2010) Perturbation of lipids and glucose metabolism associated with previous 2,4-D exposure: a cross-sectional study of NHANES III data, 1988-1994. Environmental Health 9:1.
Crossref
Anthony S Wierzbicki. (2010) Fibrates: no ACCORD on their use in the treatment of dyslipidaemia. Current Opinion in Lipidology 21:4, pages 352-358.
Crossref
Neil J. Mann, Stella L. O’Connell, Kylie M. Baldwin, Indu Singh & Barbara J. Meyer. (2010) Effects of Seal Oil and Tuna‐Fish Oil on Platelet Parameters and Plasma Lipid Levels in Healthy Subjects. Lipids 45:8, pages 669-681.
Crossref
David L. Laitinen & Shivaji Manthena. (2010) Impact of change in high-density lipoprotein cholesterol from baseline on risk for major cardiovascular events. Advances in Therapy 27:4, pages 233-244.
Crossref
Anthony S Wierzbicki. (2009) Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia. Current Opinion in Cardiology 24:4, pages 372-379.
Crossref
Genovefa D. Kolovou, Katherine K. Anagnostopoulou, Dimitris S. Damaskos, Helen I. Bilianou, Constantinos Mihas, Haralampos J. Milionis, Peggy M. Kostakou & Dennis V. Cokkinos. (2009) Gender differences in the lipid profile of dyslipidemic subjects. European Journal of Internal Medicine 20:2, pages 145-151.
Crossref
Anthony S. Wierzbicki. (2007) Raising HDL-C: back to the future?. International Journal of Clinical Practice 61:7, pages 1069-1071.
Crossref
Anthony S. Wierzbicki. (2007) Lipid-Altering Therapies and the Progression of Atherosclerotic Disease. CardioVascular and Interventional Radiology.
Crossref
Anthony S Wierzbicki. (2016) Voodoo medicine — cardiovascular trials jinxed in New Orleans. The British Journal of Diabetes & Vascular Disease 7:3, pages 142-144.
Crossref
Anthony S. Wierzbicki. (2007) Lipid-Altering Therapies and the Progression of Atherosclerotic Disease. CardioVascular and Interventional Radiology 30:2, pages 155-160.
Crossref
Anthony S Wierzbicki. (2016) Fibrates after the FIELD study: some answers, more questions. Diabetes and Vascular Disease Research 3:3, pages 166-171.
Crossref
A. S. Wierzbicki. (2006) FIELDS of dreams, fields of tears: a perspective on the fibrate trials. International Journal of Clinical Practice 60:4, pages 442-449.
Crossref
Srdjan Pesic, Miroslav Radenkovic & Leposava Grbovic. (2006) Endothelial dysfunction: Mechanisms of development and therapeutic options. Medicinski pregled 59:7-8, pages 335-341.
Crossref
C Daniel Meyers & Moti L Kashyap. (2005) Pharmacologic augmentation of high-density lipoproteins: mechanisms of currently available and emerging therapies. Current Opinion in Internal Medicine 4:5, pages 517-522.
Crossref
Anthony S Wierzbicki. (2016) The role of dyslipidaemia in coronary heart disease. The British Journal of Diabetes & Vascular Disease 5:1_suppl, pages S2-S6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.